NDUFA13 antibody (AA 159-172)
Quick Overview for NDUFA13 antibody (AA 159-172) (ABIN636278)
Target
See all NDUFA13 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 159-172
-
Cross-Reactivity (Details)
- This antibodys immunogens shares 85 % sequence identity with its Mouse and rat homologs.
-
Purification
- Affinity chromatography purified
-
Immunogen
- GRIM19 antibody was raised in rabbit using AA 159-172 QAETDRRTLQMLRE of the human GRIM-19 protein as the immunogen.
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB: 1:500-1:1,000
Optimal conditions should be determined by the investigator. -
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Buffer
- Affinity purified IgG supplied in PBS with 0.02 % NaN3.
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium Azide: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Handling Advice
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store at 4 °C for short term storage. Aliquot and store at -20 °C for long term storage.
-
-
- NDUFA13 (NADH Dehydrogenase (Ubiquinone) 1 alpha Subcomplex, 13 (NDUFA13))
-
Alternative Name
- GRIM19
-
Background
- Antisense expression of Genes associated with Retinoid-IFN-induced Mortality (GRIM), GRIM-19 confers a strong resistance against IFN/RA-induced death by reducing the intracellular levels of GRIM-19 protein. Overexpression of GRIM-19 enhances cell death in response to IFN/RA. GRIM-19 is primarily a nuclear protein whose expression is induced by the IFN/RA combination.
-
Pathways
- Protein targeting to Nucleus, Negative Regulation of intrinsic apoptotic Signaling
Target
-